Romain Guyon received the 2022 Michelson Prize for "Demonstration of new single-dose vaccine technology towards a first-in-man clinical application."
Romain Guyon is a Ph.D. student at the University of Oxford where he is developing a new technology for delayed vaccine delivery, using encapsulation by microfluidics to produce single-dose vaccines.
The Michelson Prizes: Next Generation Grants are awarded annually by the Human Immunome Project and Michelson Medical Research Foundation to support early-career investigators working to advance human immunology, vaccine discovery, and immunotherapy research for major global diseases.
For more information visit: https://www.humanimmunomeproject.org/...